Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin W McIntosh

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 7, 2004
Compliance of average- and intermediate-risk women to semiannual ovarian cancer screeningCharles W Drescher, Judy Nelson, Sue Peacock, et al.
Molecular & Cellular Proteomics : MCP|September 1, 2006
Modification of host lipid raft proteome upon hepatitis C virus replicationPetra Mannová, Ruihua Fang, Hong Wang, et al.
Gynecologic Oncology|May 11, 2007
Evaluation of the novel serum markers B7-H4, Spondin 2, and DcR3 for diagnosis and early detection of ovarian cancerIris Simon, Yan Liu, Kirstin L Krall, et al.
Plos One|December 2, 2011
Proteomics portrait of archival lesions of chronic pancreatitisSheng Pan, Ru Chen, Tyler Stevens, et al.
Journal of Proteome Research|December 25, 2008
Mass spectrometry based targeted protein quantification: methods and applicationsSheng Pan, Ruedi Aebersold, Ru Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2012
Longitudinal screening algorithm that incorporates change over time in CA125 levels identifies ovarian cancer earlier than a single-threshold ruleCharles W Drescher, Chirag Shah, Jason Thorpe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2006
Antibody immunity to the p53 oncogenic protein is a prognostic indicator in ovarian cancerVivian Goodell, Lupe G Salazar, Nicole Urban, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 11, 2012
Interpretation of single and serial measures of HE4 and CA125 in asymptomatic women at high risk for ovarian cancerNicole Urban, Jason Thorpe, Beth Y Karlan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 24, 2006
Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificityHadi Yaziji, Hector Battifora, Todd S Barry, et al.
Plos One|August 11, 2011
Impact of protein stability, cellular localization, and abundance on proteomic detection of tumor-derived proteins in plasmaQiaojun Fang, Kian Kani, Vitor M Faca, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 7, 2004
Compliance of average- and intermediate-risk women to semiannual ovarian cancer screeningCharles W Drescher, Judy Nelson, Sue Peacock, et al.
Molecular & Cellular Proteomics : MCP|September 1, 2006
Modification of host lipid raft proteome upon hepatitis C virus replicationPetra Mannová, Ruihua Fang, Hong Wang, et al.
Gynecologic Oncology|May 11, 2007
Evaluation of the novel serum markers B7-H4, Spondin 2, and DcR3 for diagnosis and early detection of ovarian cancerIris Simon, Yan Liu, Kirstin L Krall, et al.
Plos One|December 2, 2011
Proteomics portrait of archival lesions of chronic pancreatitisSheng Pan, Ru Chen, Tyler Stevens, et al.
Journal of Proteome Research|December 25, 2008
Mass spectrometry based targeted protein quantification: methods and applicationsSheng Pan, Ruedi Aebersold, Ru Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2012
Longitudinal screening algorithm that incorporates change over time in CA125 levels identifies ovarian cancer earlier than a single-threshold ruleCharles W Drescher, Chirag Shah, Jason Thorpe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2006
Antibody immunity to the p53 oncogenic protein is a prognostic indicator in ovarian cancerVivian Goodell, Lupe G Salazar, Nicole Urban, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 11, 2012
Interpretation of single and serial measures of HE4 and CA125 in asymptomatic women at high risk for ovarian cancerNicole Urban, Jason Thorpe, Beth Y Karlan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 24, 2006
Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificityHadi Yaziji, Hector Battifora, Todd S Barry, et al.
Plos One|August 11, 2011
Impact of protein stability, cellular localization, and abundance on proteomic detection of tumor-derived proteins in plasmaQiaojun Fang, Kian Kani, Vitor M Faca, et al.
Pageof 6